Sinphar Pharmaceutical Co Ltd (1734) — Cash Flow Reinvestment Rate
Sinphar Pharmaceutical Co Ltd (1734) has a Cash Flow Reinvestment Rate of 0.46x as of December 2025, reinvesting NT$91.36 Million (capex NT$67.64 Million plus investments NT$-23.72 Million) from operating cash flow of NT$200.63 Million. Explore Sinphar Pharmaceutical Co Ltd (1734) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinphar Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Sinphar Pharmaceutical Co Ltd across 22 annual periods. Also explore Sinphar Pharmaceutical Co Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sinphar Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Sinphar Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market value of Sinphar Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | NT$230.30 Million | NT$584.66 Million | NT$200.94 Million | ▼ -40.6% |
| 2024 | 0.66x | NT$393.33 Million | NT$593.51 Million | NT$256.71 Million | ▼ -69.1% |
| 2023 | 2.14x | NT$635.50 Million | NT$296.37 Million | NT$300.94 Million | ▲ +387.1% |
| 2022 | 0.44x | NT$187.21 Million | NT$425.30 Million | NT$153.44 Million | ▼ -63.1% |
| 2021 | 1.19x | NT$161.77 Million | NT$135.54 Million | NT$161.44 Million | ▲ +7.3% |
| 2020 | 1.11x | NT$162.79 Million | NT$146.39 Million | NT$157.77 Million | ▼ -73.5% |
| 2018 | 4.19x | NT$333.38 Million | NT$79.50 Million | NT$255.69 Million | ▲ +318.9% |
| 2017 | 1.00x | NT$220.09 Million | NT$219.87 Million | NT$171.00 Million | ▼ -63.3% |
| 2016 | 2.73x | NT$238.05 Million | NT$87.18 Million | NT$224.85 Million | ▲ +67.1% |
| 2015 | 1.63x | NT$458.26 Million | NT$280.53 Million | NT$412.04 Million | ▼ -27.5% |
| 2014 | 2.25x | NT$335.00 Million | NT$148.58 Million | NT$294.29 Million | ▼ -9.7% |
| 2013 | 2.50x | NT$741.65 Million | NT$297.09 Million | NT$598.16 Million | ▲ +9.4% |
| 2012 | 2.28x | NT$375.19 Million | NT$164.45 Million | NT$375.19 Million | ▲ +42.3% |
| 2011 | 1.60x | NT$361.69 Million | NT$225.58 Million | NT$361.69 Million | ▲ +43.2% |
| 2010 | 1.12x | NT$292.75 Million | NT$261.49 Million | NT$292.75 Million | ▲ +57.9% |
| 2009 | 0.71x | NT$219.71 Million | NT$309.94 Million | NT$219.71 Million | ▼ -17.6% |
| 2008 | 0.86x | NT$233.25 Million | NT$271.01 Million | NT$233.25 Million | ▼ -63.7% |
| 2007 | 2.37x | NT$414.90 Million | NT$174.85 Million | NT$414.90 Million | ▲ +58.5% |
| 2006 | 1.50x | NT$249.44 Million | NT$166.57 Million | NT$249.44 Million | ▼ -3.1% |
| 2005 | 1.55x | NT$188.76 Million | NT$122.09 Million | NT$188.76 Million | ▲ +68.1% |
| 2004 | 0.92x | NT$160.79 Million | NT$174.81 Million | NT$160.79 Million | ▼ -57.3% |
| 2003 | 2.16x | NT$260.50 Million | NT$120.84 Million | NT$260.50 Million | — |